Niacin and Calcium drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Niacin and Calcium together. This study is created by eHealthMe based on reports of 243 people who take Niacin and Calcium from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on niacin and calcium (the active ingredients of Niacin and Calcium, respectively), and Niacin and Calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Niacin?

Niacin has active ingredients of niacin. It is often used in high blood cholesterol. (latest outcomes from Niacin 7,453 users)

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. (latest outcomes from Calcium 85,927 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 12, 2019

243 people who take Niacin, Calcium are studied.


Number of reports submitted per year:

Niacin and Calcium drug interactions.

Most common drug interactions over time *:

< 1 month:

n/a

1 - 6 months:
  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Flushing (the warm, red condition of human skin)
  3. Insomnia (sleeplessness)
  4. Local swelling (swelling at the site of some application of substance or injury)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Pruritus (severe itching of the skin)
  7. Restlessness (not able to rest)
  8. Skin burning sensation
  9. Thermal burn (burn by heat)
6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:
  1. Gout (uric acid crystals building up in the body)
  2. Osteolysis (dissolution of bone)
5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Eye disorder
  3. Hypercalciuria (elevated calcium (ca+) level in the urine)
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  5. Injection site reaction
  6. International normalised ratio increased
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Muscle injury
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

Most common drug interactions by gender *:

female:
  1. Headache (pain in head)
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Drug ineffective
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Fall
  8. Oedema peripheral (superficial swelling)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Muscular weakness (muscle weakness)
male:
  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Epistaxis (bleed from the nose)
  4. Haemorrhage (bleeding)
  5. Joint swelling
  6. Pneumonia
  7. Abnormal dreams
  8. Anosmia
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Asthenia (weakness)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  2. Hepatic enzyme increased
  3. Kidney infection
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Pulmonary infarction (death of a small area of lung)
20-29:
  1. Dermatitis allergic (inflammation of the skin due allergic reaction)
  2. Drug hypersensitivity
  3. Erythema (redness of the skin)
  4. Pyrexia (fever)
40-49:
  1. Injection site pain
  2. Injection site erythema (redness at injection site)
  3. Injection site pruritus (severe itching at injection site)
  4. Asthenia (weakness)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chills (felling of cold)
  7. Constipation
  8. Dizziness
  9. Dyspepsia (indigestion)
  10. Flatulence (flatus expelled through the anus)
50-59:
  1. Atypical femur fracture
  2. Bone disorder
  3. Foot fracture
  4. Gait disturbance
  5. Hypercalciuria (elevated calcium (ca+) level in the urine)
  6. Joint dislocation (a joint position is changed from normal position)
  7. Low turnover osteopathy (slow removal of old bone and its replacement by new bone)
  8. Muscular weakness (muscle weakness)
  9. Nausea (feeling of having an urge to vomit)
  10. Upper limb fracture
60+:
  1. Arthralgia (joint pain)
  2. Drug ineffective
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Pain in extremity
  7. Anaemia (lack of blood)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Back pain

* Approximation only. Some reports may have incomplete information.


Do you take Niacin and Calcium?

You are not alone:




Related publications that referenced our studies


Results from eHealthMe (non-FDA) reports of taking Niacin and Calcium together

Drug effectiveness (drug is found to be effective) over time *:
Niacin:
  • < 1 month: 0.0% (0 of 2 people)
  • 1 - 6 months: 0.0% (0 of 3 people)
  • 6 - 12 months: 50% (1 of 2 people)
  • 1 - 2 years: 0.0% (0 of 3 people)
  • 2 - 5 years: 16% (1 of 6 people)
  • 5 - 10 years: 66% (2 of 3 people)
  • 10+ years: 33% (1 of 3 people)
  • not specified: 0.0% (0 of 0 people)
Calcium:
  • < 1 month: 0.0% (0 of 2 people)
  • 1 - 6 months: 50% (1 of 2 people)
  • 6 - 12 months: 0.0% (0 of 0 people)
  • 1 - 2 years: 100% (3 of 3 people)
  • 2 - 5 years: 25% (1 of 4 people)
  • 5 - 10 years: 100% (3 of 3 people)
  • 10+ years: 0.0% (0 of 4 people)
  • not specified: 0.0% (0 of 0 people)
Drug effectiveness (drug is found to be effective) by gender *:
Niacin:
  • female: 26% (4 of 15 people)
  • male: 14% (1 of 7 people)
Calcium:
  • female: 53% (7 of 13 people)
  • male: 20% (1 of 5 people)
Drug effectiveness (drug is found to be effective) by age *:
Niacin:
  • 0-1: 0.0% (0 of 0 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 0.0% (0 of 2 people)
  • 30-39: 0.0% (0 of 0 people)
  • 40-49: 0.0% (0 of 3 people)
  • 50-59: 50.0% (4 of 8 people)
  • 60+: 11.0% (1 of 9 people)
Calcium:
  • 0-1: 0.0% (0 of 0 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 50.0% (1 of 2 people)
  • 30-39: 0.0% (0 of 0 people)
  • 40-49: 0.0% (0 of 1 people)
  • 50-59: 57.0% (4 of 7 people)
  • 60+: 37.0% (3 of 8 people)
Race of the people *:
  • African American, Non-Hispanic: 1.49 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 2.99 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 0.0 %
  • White, Non-Hispanic: 95.52 %

* Approximation only.


Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Niacin and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Calcium and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Niacin and Calcium
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Niacin and Calcium (17,348 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.